Phosphate binders on iron basis: A new perspective?

Slides:

Advertisements

Similar presentations

Renal disease and hypertension in non–insulin-dependent diabetes mellitus Nuhad Ismail, Bryan Becker, Piotr Strzelczyk, Eberhard Ritz Kidney International.

Advertisements

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Pathophysiology of renal fluid retention

Beta blockers in the management of chronic kidney disease

Plasma sodium and hypertension

Iron status and iron supplementation in peritoneal dialysis patients

Anemia management in chronic kidney disease

Progression of renal failure and hypertensive nephrosclerosis

Dieter A. Häberle, Wolfgang Biller, Takuyuki Ise, Christian J. Metz

Pathophysiology of renal fluid retention

Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar

Is there a pharmacologic basis for combination renin axis blockade?

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 70, Pages S21-S25 (December 2006)

George A. Kaysen, Burl R. Don

How to interpret the eGFR in patients with small body surface area

A new era in phosphate binder therapy: What are the options?

Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load

Proinflammatory effects of iron sucrose in chronic kidney disease

Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion Lynda A. Frassetto, Eileen Nash,

Volume 70, Issue 11, Pages (December 2006)

Joseph W. Eschbach, John W. Adamson Kidney International

Insulin resistance in African Americans

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Nephrology Crosswords: Hemodialysis

The epidemiology of chronic kidney disease

Calcification and cardiovascular problems in renal failure

Edmund G. Lowrie Kidney International

Prevention of renal failure: The Malaysian experience

Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease S. Bianchi, R. Bigazzi, V.M. Campese

Volume 73, Pages S5-S17 (April 2008)

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

Volume 70, Issue 12, Pages (December 2006)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Recent experience with high-dose intravenous iron administration

Novel phosphate binders: plus ça change, plus c’est la même chose

The third World Kidney Day: Looking back and thinking forward

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier

Microbiology and outcomes of peritonitis in North America

Alternate-day dialysis may be needed for hemodialysis patients

Volume 79, Issue 9, Pages (May 2011)

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

AGEs in foods: Do they play a role in uremia?

Volume 67, Issue 4, Pages (April 2005)

Simvastatin in nephrotic syndrome

Counteracting progression of renal disease: A look into the future

Volume 78, Issue 5, Pages (September 2010)

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Terry Behrend, Steven B. Miller, M.D Kidney International

Volume 87, Issue 5, Pages (May 2015)

Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita Kidney International

Clinical benefits of slowing the progression of renal failure

Organ transplantation goes to the movies

Atherosclerotic nephropathy

Volume 55, Pages S3-S16 (June 1999)

Volume 80, Issue 10, Pages (November 2011)

Charles A. Herzog Kidney International

Volume 70, Issue 3, Pages (August 2006)

Volume 70, Issue 5, Pages (September 2006)

Volume 62, Issue 5, (November 2002)

Strategies for iron supplementation: Oral versus intravenous

The International Pediatric Peritonitis Registry: Starting to walk

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Ralf Dikow, Marcin Adamczak, Daniel Ernesto Henriquez, Eberhard Ritz

Renal vascular disease in the elderly

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

Volume 56, Issue 6, Pages (December 1999)

Presentation transcript:

Phosphate binders on iron basis: A new perspective? Olaf Hergesell, Eberhard Ritz Kidney International Volume 56, Pages S42-S45 (December 1999) DOI: 10.1046/j.1523-1755.1999.07311.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Percent decrease of plasma phosphate (A) and urinary phosphate excretion (B) in 13 patients with stable preterminal failure at days 14 and 28, respectively. Kidney International 1999 56, S42-S45DOI: (10.1046/j.1523-1755.1999.07311.x) Copyright © 1999 International Society of Nephrology Terms and Conditions